OpGen
is a Maryland-based biotechnology company that researches and develops molecular diagnostic therapeutics for the treatment of infectious diseases... Read moreOpGen
is a Maryland-based biotechnology company that researches and develops molecular diagnostic therapeutics for the treatment of infectious diseases... Read more
News
Nov 15, 2024
Marketscreener
OpGen: OpGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
Jun 14, 2024
Owler
OpGen, Inc.: OpGen's employee count had no change from Dec 2022 to Dec 2023
Jun 03, 2024
Owler
OpGen, Inc.: OpGen's revenue changed from $3.07M in Sep 2023 to $3.42M in Dec 2023
Jun 03, 2024
Marketscreener
OpGen: OpGen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
May 24, 2024
BioSpace
OpGen: OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q - May 24, 2024
May 16, 2024
Seeking Alpha
OpGen: OpGen to implement 1-for-10 reverse stock split
Apr 30, 2024
Citybizlist
OpGen: OpGen Provides Update on Business Operations
Apr 17, 2024
MarketScreener
OpGen: OpGen : Management Change/Compensation - Form 8-K
Mar 26, 2024
The Business Journals: Washington, D.C.
OpGen: Struggling Rockville biotech brings in new CEO to explore 'strategic options'
Mar 25, 2024
Benzinga
OpGen: OpGen Announces Acquisition of Preferred Stock by David Lazar
